Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Disease × Pluvicto × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 21 Prostatic Diseases 2 Metastatic Castration-resistant Prostate Cancer 2 Urogenital Neoplasms 1 Thrombocytopenia 1 Renal Insufficiency 1 Prostatic Neoplasms, Castration-Resistant 1 Prostate Cancer Metastatic 1 PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy 1 Neoplasms by Site 1 Neoplasms 1 Metastatic Castrate Resistant Prostate Cancer (mCRPC) 1 Male Urogenital Diseases 1 Glioma 1 Glioblastoma 1 Genital Neoplasms, Male 1 Genital Diseases, Male 1 Disease 1 Cytopenia 1 Astrocytoma 1 Anemia 1

Interventions

Magnetic Resonance Imaging 2 Blood Specimen Collection 2 tislelizumab 1 pembrolizumab 1 fluorocholine 1 atezolizumab 1 Videotape Recording 1 TIC10 compound 1 Surveys and Questionnaires 1 Specimen Handling 1 Referral and Consultation 1 Prostatectomy 1 Preoperative Exercise 1 Positron Emission Tomography Computed Tomography 1 Pluvicto 1 Observation 1 Nephroureterectomy 1 Mass Screening 1 Mammography 1 Interleukin-15 1 Endosonography 1 Diagnostic Techniques and Procedures 1 Diagnostic Imaging 1 Cryosurgery 1 Control Groups 1 Clinical Laboratory Techniques 1 Biopsy, Fine-Needle 1 Biopsy 1 Bevacizumab 1 Antigens, Neoplasm 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07054346 2025-12-01

LUTACT

University of California, San Francisco

Phase 1 Recruiting

Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡